相关实验视频

Updated: Sep 11, 2025

Directed Evolution Method in Saccharomyces cerevisiae: Mutant Library Creation and Screening

Directed Evolution Method in Saccharomyces cerevisiae: Mutant Library Creation and Screening

Published on: April 1, 2016

通过在Saccharomyces cerevisiae中稳定表达Exendin-4可获得的2型糖尿病药物

Gia Balius^1,2, Kiana Imani², Zoë Petroff²

¹Department of Molecular, Cellular and Developmental Biology, University of California, Santa Cruz, CA, United States.

Frontiers in systems biology

|August 14, 2025

概括

开发负担得起的2型糖尿病治疗方法至关重要. 这项研究探讨了在酵母中生产Exendin-4,为糖尿病管理提供了昂贵药物的潜在低成本替代品.

科学领域:

生物技术是生物技术.
分子生物学分子生物学
内分泌学在内分泌学.

背景情况:

糖尿病是一种全球性健康危机,并发症通常是由于治疗机会不足而引起的.
像Exendin-4这样的葡萄糖类1受体激活剂是有效的2型糖尿病治疗方法,但由于高成本而面临可访问性障碍.

研究的目的:

开发一种负担得起的Exendin-4的生产方法,Exendin-4是2型糖尿病的关键治疗.
在微生物系统中设计和评估重组埃克森丁-4蛋白表达,特别是大肠杆菌和麦芽菌.

主要方法:

设计用于重组Exendin-4蛋白质生产的实验模型.
使用 *Escherichia coli* 和 *Saccharomyces cerevisiae* 作为宿主生物来表达蛋白质.
通过免疫测试技术确认蛋白质表达和大小.

主要成果:

在大肠杆菌和小麦芽球菌中成功设计了用于Exendin-4生产的实验模型.
在染色体综合*S. cerevisiae*菌株中观察到预期Exendin-4大小的蛋白质表达.
通过免疫测试确认验证Exendin-4的存在和大小.

结论:

*Saccharomyces cerevisiae* 显示出作为一个可行的宿主产生负担得起的Exendin-4的潜力.
这项研究为本地,经济高效的生产和分销2型糖尿病治疗奠定了基础.
使用通常被认为是安全的酵母为改善全球获得糖尿病药物的途径提供了有希望的途径.

关键词:

埃舍里希亚大肠杆菌 (Escherichia coli) 是一个大肠杆菌.在Exendin-4中使用.药物治疗药物治疗药物治疗这种植物是Saccharomyces cerevisiae.治疗方法治疗方法 2 型糖尿病 2 型糖尿病合成生物学合成生物学

更多相关视频

In Vivo Monitoring of Transcriptional Activity During Metabolic Transition Using a Bioluminescent Reporter in Yeast

In Vivo Monitoring of Transcriptional Activity During Metabolic Transition Using a Bioluminescent Reporter in Yeast

Published on: February 21, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

相关概念视频

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Cell Specific Gene Expression

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...

Insulin Secretory Vesicles

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...